Back to Journals » Therapeutics and Clinical Risk Management » Volume 17

Italian Real-World Analysis of a Tyrosine Kinase Inhibitor Administration as First- or Second-Line of Therapy in Patients with Chronic Myeloid Leukemia

Total article views   HTML views PDF downloads Totals
1,877 Dovepress* 1,809+ 409 2,218
PubMed Central* 68 22 90
Totals 1,877 431 2,308
*Since 8 June 2021

View citations on PubMed Central and Google Scholar